Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1992 Sep;60(9):3928–3931. doi: 10.1128/iai.60.9.3928-3931.1992

Induction of circulating group II phospholipase A2 expression in adults with malaria.

P Vadas 1, J Keystone 1, E Stefanski 1, K Scott 1, W Pruzanski 1
PMCID: PMC257413  PMID: 1500203

Abstract

High levels of interleukin 1 and tumor necrosis factor are found in both cases of malaria and cases of septic shock. Since both interleukin 1 and tumor necrosis factor induce expression of the proinflammatory enzyme phospholipase A2 (PLA2), we examined serum PLA2 levels in 14 adults with malaria. Mean serum PLA2 activity was elevated 40-fold above normal (P less than 0.001). Serum PLA2 activity correlated with PLA2 immunoreactivity (r = 0.987; P less than 0.001) by an enzyme-linked immunosorbent assay specific for human group II PLA2, showing that serum PLA2 in cases of malaria is host derived. This article describes the novel finding of elevated PLA2 levels in cases of malaria, further strengthening the notion that mediators of the host response in cases of malaria are similar to those in cases of septic shock.

Full text

PDF
3928

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aung-Kyaw-Zaw, Khin-Maung-U, Myo-Thwe Endotoxaemia in complicated falciparum malaria. Trans R Soc Trop Med Hyg. 1988;82(4):513–514. doi: 10.1016/0035-9203(88)90488-9. [DOI] [PubMed] [Google Scholar]
  2. Bate C. A., Taverne J., Playfair J. H. Soluble malarial antigens are toxic and induce the production of tumour necrosis factor in vivo. Immunology. 1989 Apr;66(4):600–605. [PMC free article] [PubMed] [Google Scholar]
  3. Bomalaski J. S., Lawton P., Browning J. L. Human extracellular recombinant phospholipase A2 induces an inflammatory response in rabbit joints. J Immunol. 1991 Jun 1;146(11):3904–3910. [PubMed] [Google Scholar]
  4. Charoenpan P., Indraprasit S., Kiatboonsri S., Suvachittanont O., Tanomsup S. Pulmonary edema in severe falciparum malaria. Hemodynamic study and clinicophysiologic correlation. Chest. 1990 May;97(5):1190–1197. doi: 10.1378/chest.97.5.1190. [DOI] [PubMed] [Google Scholar]
  5. Clark I. A. Does endotoxin cause both the disease and parasite death in acute malaria and babesiosis? Lancet. 1978 Jul 8;2(8080):75–77. doi: 10.1016/s0140-6736(78)91386-7. [DOI] [PubMed] [Google Scholar]
  6. Damas P., Reuter A., Gysen P., Demonty J., Lamy M., Franchimont P. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med. 1989 Oct;17(10):975–978. doi: 10.1097/00003246-198910000-00001. [DOI] [PubMed] [Google Scholar]
  7. Debets J. M., Kampmeijer R., van der Linden M. P., Buurman W. A., van der Linden C. J. Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med. 1989 Jun;17(6):489–494. doi: 10.1097/00003246-198906000-00001. [DOI] [PubMed] [Google Scholar]
  8. Edelson J. D., Vadas P., Villar J., Mullen J. B., Pruzanski W. Acute lung injury induced by phospholipase A2. Structural and functional changes. Am Rev Respir Dis. 1991 May;143(5 Pt 1):1102–1109. doi: 10.1164/ajrccm/143.5_Pt_1.1102. [DOI] [PubMed] [Google Scholar]
  9. Gilles H. M. Malaria--an overview. J Infect. 1989 Jan;18(1):11–23. doi: 10.1016/s0163-4453(89)93517-2. [DOI] [PubMed] [Google Scholar]
  10. Grau G. E., Piguet P. F., Vassalli P., Lambert P. H. Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol Rev. 1989 Dec;112:49–70. doi: 10.1111/j.1600-065x.1989.tb00552.x. [DOI] [PubMed] [Google Scholar]
  11. Grau G. E., Taylor T. E., Molyneux M. E., Wirima J. J., Vassalli P., Hommel M., Lambert P. H. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med. 1989 Jun 15;320(24):1586–1591. doi: 10.1056/NEJM198906153202404. [DOI] [PubMed] [Google Scholar]
  12. Jakobsen P. H., Baek L., Jepsen S. Demonstration of soluble Plasmodium falciparum antigens reactive with Limulus amoebocyte lysate and polymyxin B. Parasite Immunol. 1988 Nov;10(6):593–606. doi: 10.1111/j.1365-3024.1988.tb00247.x. [DOI] [PubMed] [Google Scholar]
  13. Kumaratilake L. M., Ferrante A., Rzepczyk C. M. Tumor necrosis factor enhances neutrophil-mediated killing of Plasmodium falciparum. Infect Immun. 1990 Mar;58(3):788–793. doi: 10.1128/iai.58.3.788-793.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kwiatkowski D., Hill A. V., Sambou I., Twumasi P., Castracane J., Manogue K. R., Cerami A., Brewster D. R., Greenwood B. M. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet. 1990 Nov 17;336(8725):1201–1204. doi: 10.1016/0140-6736(90)92827-5. [DOI] [PubMed] [Google Scholar]
  15. Moll G. N., Vial H. J., van der Wiele F. C., Ancelin M. L., Roelofsen B., Slotboom A. J., de Haas G. H., van Deenen L. L., Op den Kamp J. A. Selective elimination of malaria infected erythrocytes by a modified phospholipase A2 in vitro. Biochim Biophys Acta. 1990 May 9;1024(1):189–192. doi: 10.1016/0005-2736(90)90224-c. [DOI] [PubMed] [Google Scholar]
  16. Naotunne T. S., Karunaweera N. D., Del Giudice G., Kularatne M. U., Grau G. E., Carter R., Mendis K. N. Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential. J Exp Med. 1991 Mar 1;173(3):523–529. doi: 10.1084/jem.173.3.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Picot S., Peyron F., Vuillez J. P., Barbe G., Marsh K., Ambroise-Thomas P. Tumor necrosis factor production by human macrophages stimulated in vitro by Plasmodium falciparum. Infect Immun. 1990 Jan;58(1):214–216. doi: 10.1128/iai.58.1.214-216.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Playfair J. H., Taverne J. Antiparasitic effects of tumour necrosis factor in vivo and in vitro. Ciba Found Symp. 1987;131:192–205. doi: 10.1002/9780470513521.ch13. [DOI] [PubMed] [Google Scholar]
  19. Playfair J. H., Taverne J., Bate C. A., de Souza J. B. The malaria vaccine: anti-parasite or anti-disease? Immunol Today. 1990 Jan;11(1):25–27. doi: 10.1016/0167-5699(90)90007-v. [DOI] [PubMed] [Google Scholar]
  20. Pruzanski W., Vadas P. Phospholipase A2--a mediator between proximal and distal effectors of inflammation. Immunol Today. 1991 May;12(5):143–146. doi: 10.1016/S0167-5699(05)80042-8. [DOI] [PubMed] [Google Scholar]
  21. Pruzanski W., Vadas P. Soluble phospholipase A2 in human pathology: clinical-laboratory interface. Adv Exp Med Biol. 1990;279:239–251. doi: 10.1007/978-1-4613-0651-1_17. [DOI] [PubMed] [Google Scholar]
  22. Rosenblum M. G., Donato N. J. Tumor necrosis factor alpha: a multifaceted peptide hormone. Crit Rev Immunol. 1989;9(1):21–44. [PubMed] [Google Scholar]
  23. Smith G. M., Ward R. L., McGuigan L., Rajkovic I. A., Scott K. F. Measurement of human phospholipase A2 in arthritis plasma using a newly developed sandwich ELISA. Br J Rheumatol. 1992 Mar;31(3):175–178. doi: 10.1093/rheumatology/31.3.175. [DOI] [PubMed] [Google Scholar]
  24. Taverne J., Bate C. A., Sarkar D. A., Meager A., Rook G. A., Playfair J. H. Human and murine macrophages produce TNF in response to soluble antigens of Plasmodium falciparum. Parasite Immunol. 1990 Jan;12(1):33–43. doi: 10.1111/j.1365-3024.1990.tb00934.x. [DOI] [PubMed] [Google Scholar]
  25. Taverne J., Tavernier J., Fiers W., Playfair J. H. Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro. Clin Exp Immunol. 1987 Jan;67(1):1–4. [PMC free article] [PubMed] [Google Scholar]
  26. Tracey K. J., Beutler B., Lowry S. F., Merryweather J., Wolpe S., Milsark I. W., Hariri R. J., Fahey T. J., 3rd, Zentella A., Albert J. D. Shock and tissue injury induced by recombinant human cachectin. Science. 1986 Oct 24;234(4775):470–474. doi: 10.1126/science.3764421. [DOI] [PubMed] [Google Scholar]
  27. Tracey K. J., Fong Y., Hesse D. G., Manogue K. R., Lee A. T., Kuo G. C., Lowry S. F., Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 1987 Dec 17;330(6149):662–664. doi: 10.1038/330662a0. [DOI] [PubMed] [Google Scholar]
  28. Tubbs H. Endotoxin in human and murine malaria. Trans R Soc Trop Med Hyg. 1980;74(1):121–123. doi: 10.1016/0035-9203(80)90026-7. [DOI] [PubMed] [Google Scholar]
  29. Vadas P., Pruzanski W. Phospholipase A2 activation is the pivotal step in the effector pathway of inflammation. Adv Exp Med Biol. 1990;275:83–101. doi: 10.1007/978-1-4684-5805-3_5. [DOI] [PubMed] [Google Scholar]
  30. Vadas P., Pruzanski W., Stefanski E., Ellies L. G., Aubin J. E., Sos A., Melcher A. Extracellular phospholipase A2 secretion is a common effector pathway of interleukin-1 and tumour necrosis factor action. Immunol Lett. 1991 Jun;28(3):187–193. doi: 10.1016/0165-2478(91)90002-r. [DOI] [PubMed] [Google Scholar]
  31. Vadas P., Pruzanski W., Stefanski E. Extracellular phospholipase A2: causative agent in circulatory collapse of septic shock? Agents Actions. 1988 Jul;24(3-4):320–325. doi: 10.1007/BF02028289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Vadas P., Pruzanski W., Stefanski E., Sternby B., Mustard R., Bohnen J., Fraser I., Farewell V., Bombardier C. Pathogenesis of hypotension in septic shock: correlation of circulating phospholipase A2 levels with circulatory collapse. Crit Care Med. 1988 Jan;16(1):1–7. doi: 10.1097/00003246-198801000-00001. [DOI] [PubMed] [Google Scholar]
  33. Van Zee K. J., DeForge L. E., Fischer E., Marano M. A., Kenney J. S., Remick D. G., Lowry S. F., Moldawer L. L. IL-8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol. 1991 May 15;146(10):3478–3482. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES